125TiP SGNTUC-019: Phase II basket study of tucatinib and trastuzumab in previously treated solid tumours with HER2 alterations: HER2-mutated breast cancer cohort von Okines, A., Kang, V., Walker, L.N., Pohlmann, P.R.

Volltext

3 Oral: Tucatinib and Trastuzumab for Patients With Previously Treated, HER2- Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study von Nakamura, Y., Bekaii-Saab, T., Hamilton, E., Hayashi, H., Mizuno, N., Monk, B.J., Nguyen, D., Okines, A., O’Malley, D.M., Pohlmann, P.R., Pothuri, B., Reck, M., Sudo, K., Sunakawa, Y., Takahashi, S., Yu, E.Y., Drees, A., Tan, S., Stinchcombe, T.E.

Volltext

Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical t... von Huppert, L.A., Wolf, D., Yau, C., Brown-Swigart, L., Hirst, G.L., Isaacs, C., Pusztai, L., Pohlmann, P.R., DeMichele, A., Shatsky, R., Yee, D., Thomas, A., Nanda, R., Perlmutter, J., Heditsian, D., Hylton, N., Symmans, F., van’t Veer, L.J., Esserman, L., Rugo, H.S.

Volltext

557TiP SGNTUC-019: Phase II basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations von Reck, M., Okines, A., Pohlmann, P.R., Yu, E., Bekaii-Saab, T., Nakamura, Y., Monk, B.J., O'Malley, D., Kang, V., Walker, L.N., Stinchcombe, T.

Volltext

314P The impact of changes in tumor mutational landscape during neoadjuvant therapy on tumor-informed ctDNA testing in breast cancer patients von Magbanua, M., Rivero-Hinojosa, S., Sayaman, R., Tin, T., Kalashnikova, E., Wolf, D., Brown-Swigart, L., Hirst, G., Yau, C., Isaacs, C., Shatsky, R.A., Delson, A., Palsuledesai, C.C., Rodriguez, A.A., Liu, M.C., Pohlmann, P.R., Esserman, L., Rugo, H.S., DeMichele, A., Veer, L.J. Van't

Volltext

132P Neoadjuvant zanidatamab for stage I node-negative HER2- positive breast cancer (BC) von Valero, V., Mouabbi, J., Alonzo, H., Ilheme, A. Nwosu, Murthy, R., Huang, X., Qiao, W., Patel, M., Pohlmann, P.R., Rauch, G., Checka, C., Hunt, K., Tripathy, D., Meric-Bernstam, F., Symmans, F.

Volltext

CXCL8 secretion by dendritic cells predicts contact allergens from irritants von Toebak, M.J., Pohlmann, P.R., Sampat-Sardjoepersad, S.C., von Blomberg, B.M.E., Bruynzeel, D.P., Scheper, R.J., Rustemeyer, T., Gibbs, S.

Volltext

Accuracy of frozen‐section analysis in the diagnosis of ovarian tumors: a systematic quantitative review von Medeiros, L.R., Rosa, D.D., Edelweiss, M.I., Stein, A.T., Bozzetti, M.C., Zelmanowicz, A., Pohlmann, P.R., Meurer, L., Carballo, M.T.

Volltext

Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells von Pinedo, H.M, Buter, J, Luykx-de Bakker, S.A, Pohlmann, P.R, van Hensbergen, Y, Heideman, D.A.M, van Diest, P.J, de Gruijl, T.D, van der Wall, E

Volltext

Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF von Pinedo, H.M, Buter, J, Luykx-de Bakker, S.A, Pohlmann, P.R, van Hensbergen, Y, Heideman, D.A.M, van Diest, P.J, de Gruijl, T.D, van der Wall, E

Volltext